CSTD Manufacturing Facility Costs US$30 Million
Equashield will invest an estimated $30 million to build the new plant to meet the growing market demand for manual and automated hazardous drug compounding devices.
Equashield will invest an estimated $30 million to build the new plant to meet the growing market demand for manual and automated hazardous drug compounding devices.